September 28, 2023

ARMIS BIOPHARMA® Announces Receipt of a $20.3 Million Contract with the Defense Threat Reduction Agency to Develop Veriox® DECON for Battlefield Wounds

September 28, 2023

Armis Biopharma® Announces 510(k) Clearance for VeriCyn® Wound Wash

September 28, 2023

VERIOX® DECON IS SHOWN TO KILL BIOLOGICAL WARFARE AGENT, ANTHRAX

September 28, 2023

Armis Biopharma® Announces Release of Phase 2 Grant Award from the National Institutes of Health

September 28, 2023

ARMIS BIOPHARMA® DONATES ARMICLENZ® TO CONVOY OF HOPE FOR HURRICANE IDA VICTIMS

September 28, 2023

Armis Biopharma® Announces 510(k) Clearance for VeriFixx^TM Small Bone Implant

September 28, 2023

ARMIS BIOPHARMA® Announces Grant Award from the National Institutes of Health